Back
Cirrus Logic 10K Form
Buy
58
CRUS
Cirrus Logic
Last Price:
104.66
Seasonality Move:
5.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-06 | 10Q | CRUS/Cirrus Logic Quarterly |
2023-11-02 | 10Q | CRUS/Cirrus Logic Quarterly |
2023-08-03 | 10Q | CRUS/Cirrus Logic Quarterly |
2023-02-02 | 10Q | CRUS/Cirrus Logic Quarterly |
2022-11-01 | 10Q | CRUS/Cirrus Logic Quarterly |
2022-08-02 | 10Q | CRUS/Cirrus Logic Quarterly |
Receive CRUS News And Ratings
See the #1 stock for the next 7 days that we like better than CRUS
CRUS Financial Statistics
Sales & Book Value
Annual Sales: | $1.79B |
---|---|
Cash Flow: | $5.49M |
Price / Cash Flow: | 10.61 |
Annual Sales: | $36.29 |
Price / Book: | 2.89 |
Profitability
EPS (TTM): | 5.90000 |
---|---|
Net Income (TTM): | $327.8M |
Gross Margin: | $916.07M |
Return on Equity: | 18.01% |
Return on Assets: | 14.67% |
Cirrus Logic Earnings Forecast
Key Cirrus Logic Financial Ratios
- The Gross Profit Margin over the past 37 years for CRUS is 51.21%.
- The Selling, General & Administrative Expenses for CRUS have been equal to 8.06% of Gross Profit Margin.
- The Research & Development expenses have been 23.84% of Revenue.
- The Interest Expense is 0.33% of Operating Income.
- The Net Earning history of CRUS is 15.35% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 21 years.
Cirrus Logic Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | CRUS |
CUSIP: | 172755 |
Website: | cirrus.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.34 |
Quick Ratio: | 3.5 |
Price-to-Earnings
Trailing P/E Ratio: | 21.37 |
---|---|
Forward P/E Ratio: | 15.72 |
CRUS Technical Analysis vs Fundamental Analysis
Buy
58
Cirrus Logic (CRUS)
is a Buy
Is Cirrus Logic a Buy or a Sell?
-
Cirrus Logic stock is rated a Buy
The current Cirrus Logic [CRUS] share price is $104.73. The Score for CRUS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.